Ben Robbins is a general partner at GV, investing across healthcare delivery and neuropsychiatric therapeutics. As a psychiatrist by background, Ben leads GV’s investments in mental health-related companies, including Firsthand, Headway, and Brightline. His investments also include Aspire (acquired by Anthem), Rodin (acquired by Alkermes), Carebridge, Guidelight, Patina, Waltz Health, Nym, and Cerevance. Previously, Ben completed psychiatric training at Massachusetts General Hospital and Mclean Hospital, the top and second-ranked departments of psychiatry in the United States. He also co-founded a n...read more